(Q36591428)

15 August 2017

title

Clinical outcome of anaplastic thyroid carcinoma treated with radiotherapy of once- and twice-daily fractionation regimens (English)

1 reference

Adaptive radiation therapy

15 August 2017

main subject

0 references

thyroid carcinoma

1 reference

anaplastic thyroid carcinoma

inferred from title

1 reference

Brendan Dickson

4

0 references

Richard W. Tsang

object named as

Richard Tsang

2

0 references

Sylvia L. Asa

object named as

Sylvia Asa

3

0 references

Tamara Arenovich

5

object named as

Tamara Arenovich

1 reference

15 August 2017

Yongjin Wang

1

1 reference

15 August 2017

James Brierley

6

1 reference

15 August 2017

language of work or name

English

0 references

publication date

1 October 2006

1 reference

15 August 2017

1 reference

15 August 2017

volume

107

1 reference

15 August 2017

issue

8

1 reference

15 August 2017

page(s)

1786-1792

1 reference

A National Cancer Data Base report on 53,856 cases of thyroid carcinoma treated in the U.S., 1985-1995 [see commetns]

15 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22203

7 January 2021

Immediate causes of death in thyroid carcinoma: clinicopathological analysis of 161 fatal cases

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22203

7 January 2021

Anaplastic thyroid cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22203

7 January 2021

Rare tumors of the thyroid gland

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22203

7 January 2021

Anaplastic thyroid carcinoma. Treatment outcome and prognostic factors

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22203

7 January 2021

Anaplastic carcinoma of the thyroid: a clinicopathologic study of 82 cases

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22203

7 January 2021

Anaplastic carcinoma of the thyroid: a 24-year experience

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22203

7 January 2021

Anaplastic (undifferentiated) thyroid carcinoma (ATC). A retrospective analysis

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22203

7 January 2021

The effect of surgery and radiotherapy on outcome of anaplastic thyroid carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22203

7 January 2021

Combined treatment of anaplastic thyroid carcinoma with surgery, chemotherapy, and hyperfractionated accelerated external radiotherapy

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22203

7 January 2021

Treatment of anaplastic thyroid carcinoma with paclitaxel: phase 2 trial using ninety-six-hour infusion. Collaborative Anaplastic Thyroid Cancer Health Intervention Trials (CATCHIT) Group

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22203

7 January 2021

Combination therapy for anaplastic giant cell thyroid carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22203

7 January 2021

Chemotherapy for thyroid cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22203

7 January 2021

A randomized trial of doxorubicin versus doxorubicin plus cisplatin in patients with advanced thyroid carcinoma.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22203

7 January 2021

Anaplastic thyroid carcinoma: a 50-year experience at a single institution

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22203

7 January 2021

Combined doxorubicin, hyperfractionated radiotherapy, and surgery in anaplastic thyroid carcinoma. Report on two protocols. The Swedish Anaplastic Thyroid Cancer Group

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22203

7 January 2021

Anaplastic giant cell carcinoma of the thyroid gland: treatment and survival over a 25-year period

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22203

7 January 2021

Anaplastic thyroid carcinoma: three protocols combining doxorubicin, hyperfractionated radiotherapy and surgery

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22203

7 January 2021

Multimodal therapy in anaplastic giant cell thyroid carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22203

7 January 2021

Treatment of locally advanced thyroid carcinoma with combination doxorubicin and radiation therapy

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22203

7 January 2021

Phase II evaluation of high dose accelerated radiotherapy for anaplastic thyroid carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22203

7 January 2021

Myelopathy following hyperfractionated accelerated radiotherapy for anaplastic thyroid carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22203

7 January 2021

Completely resected anaplastic thyroid carcinoma combined with adjuvant chemotherapy and irradiation is associated with prolonged survival

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22203

7 January 2021

Identifiers

DOI

10.1002/CNCR.22203

1 reference

15 August 2017

1 reference